Insuman Rapid Solostar

Insulin Human, the active ingredient in Insuman Rapid Solostar, is an insulin presented as a sterile solution for subcutaneous use. It is used to control blood glucose levels in people with diabetes mellitus. GNH USA supplies Insuman Rapid Solostar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Rapid Solostar is a rapid‑acting insulin that works within the carbohydrate metabolism pathway to lower blood glucose. - Type 1 Diabetes: provides prompt reduction of elevated glucose levels after meals. - Type 2 Diabetes: improves overall glycaemic control when oral agents are insufficient. - Diabetic Ketoacidosis: supplies rapid insulin to correct hyperglycaemia and suppress ketone production.

Insuman Rapid Solostar may cause a range of adverse reactions.

Common Side Effects: - Hypoglycaemia: symptoms of low blood sugar such as sweating, tremor, or confusion. - Injection‑site reactions: redness, swelling, or itching at the injection site. - Weight gain: increased caloric storage associated with improved glucose utilisation. - Lipodystrophy: localized changes in subcutaneous fat with repeated injections. - Mild allergic response: rash or urticaria. - Transient nausea: occasional stomach discomfort after injection.

Serious or Rare Side Effects: - Severe hypoglycaemia: seizures, loss of consciousness, or coma. - Anaphylactic reaction: difficulty breathing, swelling of face or throat. - Hypokalemia: low potassium levels leading to muscle weakness or arrhythmia. - Persistent hyperglycaemia: unexpected high blood glucose despite dosing. - Edema: swelling of extremities due to fluid retention. - Insulin antibody formation: reduced drug efficacy over time.

When using Insuman Rapid Solostar, consider the following precautions. - Dose adjustment: titrate dose based on frequent blood glucose monitoring. - Hypoglycaemia risk: avoid administration if blood glucose is already low. - Renal or hepatic impairment: monitor closely and adjust dose as needed. - Pregnancy and lactation: safety not fully established; use only if benefits outweigh risks. - Driving and operating machinery: be aware of possible hypoglycaemia‑related impairment. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake the vial.

Insuman Rapid Solostar can interact with several other medicines.

Major Interactions (Avoid): - Sulfonylureas or meglitinides: combined use may cause severe hypoglycaemia. - Beta‑blockers: may mask hypoglycaemia symptoms, delaying recognition. - Alcohol: can potentiate insulin’s glucose‑lowering effect, increasing hypoglycaemia risk.

Moderate Interactions (Monitor Closely): - Thiazolidinediones: additive glucose‑lowering effect, require glucose monitoring. - ACE inhibitors or ARBs: may enhance insulin sensitivity, modestly lowering glucose. - Diuretics: can affect electrolyte balance, influencing insulin action.